Abstract. mAbs bd 17, bd 24, and bd 28 raised against bovine cerebral 3,-aminobutyric acid (GABAA)/ benzodiazepine receptors were analyzed for their ability to detect each of 12 GABAA receptor subunits expressed in cultured mammalian cells. Results showed that mAb bd 17 recognizes epitopes on both f12 and f13 subunits while mAb bd 24 is selective for the aj subunit of human and bovine, but not of rat origin.
Abstract. mAbs bd 17, bd 24, and bd 28 raised against bovine cerebral 3,-aminobutyric acid (GABAA)/ benzodiazepine receptors were analyzed for their ability to detect each of 12 GABAA receptor subunits expressed in cultured mammalian cells. Results showed that mAb bd 17 recognizes epitopes on both f12 and f13 subunits while mAb bd 24 is selective for the aj subunit of human and bovine, but not of rat origin.
The latter antibody reacts with the rat c~ subunit carrying an engineered Leu at position four, documenting the first epitope mapping of a GABAA receptor subunit-specific mAb. In contrast to mAbs bd 17 and bd 24, mAb bd 28 reacts with all GABAA receptor subunits tested but not with a glycine receptor subunit, suggesting the presence of shared epitopes on subunits of GABA-gated chloride channels.
~
-AMINOBUTYRIC ACID (GABA) ~ is the major inhibitory neurotransmitter in the mammalian central nervous system and gates a chloride-conducting channel intrinsic to the GABAA receptor. GABA-gated channel activity leading to neuronal hyperpolarization can be modulated by a variety of compounds, e.g., benzodiazepines and barbiturates, some of which are in clinical use (for review, see Olsen and Venter, 1986) . The GABAA receptor complex has been purified from several species (Sigel et al., 1983; Schoch et al., 1984; Sweetnam et al., 1987; Barnard et al., 1987; Bureau and Olsen, 1988) by affinity chromatography using the immobilized benzodiazepine Ro7-1986/1. This receptor is resolved by gel electrophoresis into two major bands with Mr of 50 (termed o0 and 55 kD (termed fl), as well as several minor bands, up to an Mr of ~59 kD (Fuchs et al., 1988) .
The molecular cloning of cDNAs encoding GABAA receptor subunits showed that these subunits share sequence similarities with subunits of both the glycine receptor (Grenningloh et al., 1987) and the nicotinic acetylcholine receptor (Schofield et al., 1987) , indicating that GABAA receptors may well consist of a pentameric arrangement of subunits (for review, see Unwin, 1989) . Although these cloning studies have revealed the existence of a large family of GABAA receptor subunits, suggesting extensive receptor heterogeneity, the exact subunit composition and stoichiometry of a natural GABAA receptor has yet to be determined. In particular, several variants of both the ct and fl subunit classes are sequence characterized (Levitan et al., 1988; Ymer et ai., 1989 a, b; Pritchett and Seeburg, 1990) , and the existence of members of novel subunit classes is docu-mented (Pritchett et al., 1989b; Shivers et al., 1989) . As a consequence similarities in predicted size and the unknown extent of glycosylation have hampered the direct assignment of gel-resolved receptor polypeptides to cloned subunits.
Photoaffinity labeling of tritiated receptor ligands as well as mAbs have been used extensively to characterize the GABAA receptor constituents. Similarly, these tools have been employed in radio-and immunohistochemistry to characterize the distribution of this important receptor in the mammalian central nervous system (M6hler et al., 1980; Schoch et al., 1985; Stephenson et al., 1986; Richards et al., 1987; Sieghart et al., 1987; de Bias et al., 1988; Houser et al., 1988; Somogyi et al., 1989) . However, the molecular heterogeneity of this receptor raises the issue of subunit specificity of these antibodies.
Three mAbs, bd 17, bd 24, and bd 28 developed in one of our laboratories (H/iring et al., 1985) have been employed successfully in the characterization and localization of GABAA receptors (Schoch et al., 1984 H~ring et al., 1985; Richards et al., 1987; Houser et al., 1988; Fuchs et al., 1988) . Antibody bd 17 binds to a 55-kD polypeptide and has been designated as/~-subunit specific (H~iring et al., 1985) . Antibody bd 24 specifically reacts with a 50-kD polypeptide thought to represent a particular oe-subunit. Tritiated flunitrazepam photolabels this polypeptide and additionally proteins of Mr 53 and 59 kD. These larger proteins as well as the 50-kD polypeptide reacted with mAb bd 28, which suggested that this antibody is c~ subunit-specific Fuchs et al., 1988) . Using an array of cultured cells transiently expressing 12 GABAA receptor subunits and a glycine receptor subunit, we show that mAbs bd 17 and bd 24 are highly subunit specific, while mAb bd 28 reacts with all GABAA receptor subunits tested. We also determined the epitope recognized by mAb bd 24.
Materials and Methods

Transfection of Cultured Cells
Transformed human embryonic kidney cells 293 (ATCC CRL 1573) (Gorman et al., 1989) were grown at 37°C on coverglass coated with fibronectin (25 #g/ttl in PBS) in MEM (Gibco Laboratories, Grand Island, NY) supplemented with 10% FBS containing 100 U of penicillin (Gibco Laboratories) and 100 #g of streptomycin (Gibco Laboratories) per ml in a 5% CO.,/95% air incubator. Exponentially growing cells were trypsinized and seeded at 2 x 105 per coverglass in 2 ml of growth medium. The transfection was performed by using the calcium phosphate precipitation technique (Chen and Okayama, 1987) . The cloned cDNAs of human GABAA receptor subunits, inserted singly into the eukaryotic expression vector CIS2 (Pritchett et al., 1988; Gorman et al., 1989) or CDM8 (Ymer et al., 1989 a, b) , were used for transfection. The cells were incubated in the presence (2 #g/ml) of one or several supercoiled expression plasmids for 12-16 h at 37°C under 3% CO2/97% air. The medium was removed, and the cells were rinsed twice with culture medium, refed, and incubated in the same medium for 24 h at 37°C under 5% CO2/95% air before beginning the immunological studies.
Immunocytochemistry
Medium was removed by aspiration and cells were washed twice with 10 mM PBS, pH 7.4. Fixation was performed in 3% PBS-buffered paraformaldehyde for 5 min. Cells were rinsed twice with PBS and incubated with 50 mM glycine in PBS. In some cases, cells were permeabilized by the addition of 0.3% Triton X-100. After an additional 5 rain, 1% blocking serum (Vectastain ABC kit; Vector Laboratories, Burlingame, CA) was applied for 30 rain. The mAbs were added to cells for 2-3 h in a 1:5 dilution using supernatants of cultured hybridoma cells. Coverglasses with cells were washed gently with PBS and the second biotinylated antiserum (Vectastain 1:200) was added for 60 rain. After washing with PBS the avidin-biotinylated HRP complex (1:100) was applied for 1.5 h. Cells were rinsed with PBS and the reaction was started by incubation in PBS containing 0.05% diaminobenzidine/0.03% H202 typically for 5-15 min. To stop this reaction, cells were again rinsed with PBS. Coverglasses were dipped for a few seconds into distilled water and mounted on glass microscope slides with Moviol (Hoechst AG, FRG).
lnsertional Mutagenesis
The single-stranded M13 nap 18 DNA, containing the cloned rat t~l GABAA receptor subunit cDNA, served as a template for insertional oligonucleotide-mediated DNA synthesis (Adelman et al., 1983) in the presence of E. coli polymerase I, Klenow fragment (Boehringer Mannheim Biochemicals, Indianapolis, IN), and dATP, dTTP, dGTP, and dCTPaS (Taylor et al., 1985) . The oligonucleotide (5'-TATGGACAGCCCTCCT/'ACAAGAT-GAACTT-3') was complementary to the sequence encoding the amino acid residues YGQPSLQDEL, and specified an additional leucine codon at position four of the rat at polypeptide sequence. The mutant detection system developed by Eckstein and collaborators (Taylor et al., 1985) was employed to minimize screening efforts, using conditions as specified in the protocol accompanying the Amersham Corp. in vitro mutagenesis kit (Arlington Heights, IL). Resulting MI3 plaques were analyzed by DNA sequencing (Sanger et al., 1977) . For eukaryotic expression, the cDNA fragments containing the entire coding regions for the wild type and mutated rat st subunits were excised with endonucleases Hind 1II and Pst I from the respective MI3 DNAs after double-strand DNA synthesis primed with the lac 17-mer primer (Messing et al., 1981) . These DNA fragments were gel purified and cloned into linearized CDM8 vector DNA (Invitrogen, San Diego. CA).
Results
Single GABAA receptor subunits as well as subunit combinations can be transiently expressed in cultured mammalian cells and the receptors which form in these cells can be readily characterized by pharmacological and electrophysiological means (Pritchett et al., 1988 (Pritchett et al., , 1989a Shivers et al., 1989) . We have used this system to investigate the specificity of mAbs bd 17, bd 24, and bd 28 in their detection of 12 GABAA receptor subunits. Human embryonic kidney cells grown on coverslips were transfected with expression vectors containing cloned cDNAs that encode these subunits. After subunit expression, fixed, and either permeabilized or nonpermeabilized cells, were incubated with the antibodies which, in turn, were visualized by the avidin-biotinylated HRP method. Neither untransfected nor mock-transfected 293 cells showed immunoreactivity with any of the three antibodies (Fig.  1 a) .
Displaying high specificity, mAb bd 24 reacted only with bovine and human c~, subunits (Fig. 1 b) , but did not detect the c~, subunit of rat origin. This antibody did not react with any other c~ subunit variant nor any of the other members of the known GABAA receptor subunit classes. Thus, it appears that mAb bd 24 is specific for the c~ subunit of selected species.
The mAb bd 17 displayed intensive staining of cells expressing the rat /33 subunit (Fig. 1 c) , a reproducibly weaker reaction with the rat ~2 subunit and no staining with rat or human fl~ subunits. No other GABAA receptor subunit was recognized by this mAb (Fig. 2) . These results confirm that bd 17 is ~-subunit specific as proposed previously Fuchs et al., 1988) . However, mAb bd 17 is selective for ft., and f13 subunits and fails to react with the fit subunit.
In marked contrast to the specificity of mAbs bd 17 and bd 24, mAb bd 28 recognized all six ~ subunits, although with different intensities (Fig. 2) , and reacted additionally with fl, 3' (Fig. 1 d) , and t5 subunits. This nonselectivity of mAb bd 28 suggested that it might also bind to subunits of the glycine receptor, as subunits of GABAA and glycine receptors are highly homologous Grenningloh et al., 1987; Schofield et al., 1987) . However, no immunocytochemical reaction was observed upon expression of the 48-kD glycine receptor subunit (Grenningloh et al., 1987) , although this subunit was detected by mAb 4 specific for the glycine receptor (Pfeiffer et al., 1984; Becker et al., 1988) . Hence, GABAA receptor subunits may share epitopes not present on the glycine receptor.
In nonpermeabilized cells the antibodies have access only to epitopes located at the outer surface of the plasma membrane. Under these conditions, mAbs bd 24 and bd 17 did, while bd 28 did not, immunoreact with all GABAA receptor subunits detected in permeabilized cells. This indicates extracellularly located epitopes for mAbs bd 24 and bd 17, while the epitope recognized by mAb bd 28 is either intracellularly located or hidden in a folded structure within the extraceilular domain. We favor the latter possibility since the extracellular domain of the 6 subunit contained in a bacterial fusion protein reacted in an ELISA with mAb bd 28 when pretreated with Triton X-100 (not shown). However, in sections of rat brain, mAb bd 28 did not yield an immunoreaction even after treatment with detergent (J. G. Richards, personal communication) .
Sequence comparisons among the GABA^ receptor subunits failed to reveal likely epitopes for bd 17 and bd 28, indicating that features other than primary structure may determine the reactivity of these antibodies. However, comparison of the ct~ subunit sequences from three species was more informative as it revealed very few amino acid substitutions. In particular, an extra leucine residue occurs in position four of the predicted mature extracellular domain of the bovine and human versus the rat ot~ subunits. To test whether this difference correlates with the species selectivity of mAb bd 24, we inserted the leucine residue by sitedirected mutagenesis into the appropriate position of the cloned rat a, subunit cDNA. Upon expression, the mutated rat at subunit indeed reacted with mAb bd 24 (Fig. 3) . As predicted, both the normal and mutated rat cz, subunits were detected by mAb bd 28 in a control experiment. Further support that mAb bd 24 specifically recognizes this epitope is provided by the positive reaction of the antibody to an immobilized 14-mer peptide covering amino acid residues 1-14 of the bovine GABAA receptor ix, subunit (not shown).
D i s c u s s i o n
We have tested the specificity of subunit recognition by the three most widely used mAbs for GABAA receptor characterization and immunocytochemistry. Two of these antibodies displayed a high specificity towards particular subunits. Thus, bd 17 is clearly selective for subunits of the/3 class, detecting/52 and B3, though it does not show any reactivity towards the B~ subunit (Figs. 1 and 2) . The latter subunit is the least expressed among the /3 subunits in the CNS as judged by Northern analysis (Ymer et ai., 1989 b) . Sequence comparisons among the three/3 subunits did not give any clues as to which epitope mediates 132 and/53 subunit recognition by mAb bd 17. In brain sections, bd 17 recognizes GABAA receptors with the pattern of epitope distribution Figure 2 . Differential reactivity of mAbs bd 17, bd 24, and bd 28 towards 12 GABAA receptor subunits and a glycine receptor subunit. The different shadings of each field represent the immunoreactivities of mAbs with specific GABAA receptor subunits. The following GABAA receptor subunits from the following species were tested: a~, rat, bovine, human (r, b, h); ~2, h; or3, h; a4, b (Ymer et ai., 1989a) ; ~5, r (Khrestchatisky et al., 1989; Pritchett and Seeburg, 1990 ); ~6, b; BJ, r and h;/32, r; ~3, r; 3'~, h; 3'2, h; (5, r; Gly 48K, r and h. often corresponding to the distribution of radioligand binding sites Richards et al., 1987) . Thus, in the absence of data from high-resolution immunocytochemistry, the f12 and/or f13 subunits seem frequently components of natural GABAA receptors. Antibody bd 24 presented the highest selectivity because it reacted solely with the a~ subunit of human and bovine origin but failed to react with rat ot~ (Figs. 1 and 2 ). This species specificity has been noticed previously (H/iring et al., 1985) . However, the selectivity for at excluding all other a subunits, documented here, had not been previously appreciated. Currently, six ~ subunits are characterized (Schofield et al., 1987 Ymer et al., 1989a; Khrestchatisky et al., 1989; Pritchett and Seeburg, 1990 ) that display ~70% sequence homology in their extracellular domain (>80%). Hence the selectivity ofmAb bd 24 makes this antibody a particularly useful tool to study otz subunit-containing GABAA receptors. The latter receptors are highly expressed in many parts of the mammalian central nervous system and are constituents of the pharmacologically important BZ I type of GABAA/benzodiazepine receptors (Pritchett et al., 1989a) . In sections of brain from several species, the epitope distribution for mAb bd 24 is very similar to that of mAb bd 17 Richards et al., 1988; Somogyi et al., 1989) . Thus, the natural GABAA/benzodiazepine receptors frequently contain o~ subunits in some combination with/3z and/or f13 subunits.
In stark contrast to mAbs bd 17 and bd 24, mAb bd 28 is indiscriminate in its binding to all GABAA receptor subunits tested (Figs. 1 and 2) . Interestingly, it reacts with subunits of all classes including the fl and t5 classes having low homology to ot subunits. Although mAb bd 28 reacts with all subunits, the extent of this reaction is not as uniform as oe4, fl~, and f13 subunits are less intensively stained. Such lower reactivity could be due to a reduced expression efficiency of these subunits. While we cannot investigate this possibility due to the lack of subtype-specific antibodies, we would like to stress that DNA constructs for expression of the fl~ and a4 subunits injected into Xenopus oocyte nuclei lead to large chloride currents upon superfusion with GABA (Ymer et al., 1989a) . The lack of selectivity of mAb bd 28 is unexpected considering earlier findings in which bd 28 reacted mainly with ot subunit proteins in Western blots Fuchs et al., 1988) . The epitope recognized by this antibody may not be preserved to the same extent in all subunits under Western blot conditions.
As for mAb bd 17, a sequence search among GABAA receptor subunits for a common epitope to account for mAb bd 28 recognition was unsuccessful. Our finding that mAb bd 28 does not react with the 48-kD subunit of the glycine receptor although subunits of both receptors share '~35 % sequence similarity points to an epitope unique to GABAA receptor subunits Grenningloh et ai., 1987; Schofield et al., 1987) . This extent of sequence similarity is also found between members of different classes of GABAA receptor subunits. A successful epitope characterization was achieved in the case of mAb bd 24 where a leucine residue present in the human and bovine o~ subunits, but absent in the rat homologue, was identified as an essential part of the specific epitope recognized by this antibody (Fig. 3) .
The present characterization should greatly aid in the interpretation of immunocytochemical results obtained with the use of these mAbs. Our present studies underscore the importance of determining the specificities of antibodies directed against subunits of ligand-gated ion channels. As these subunits are members of the large gene family with significant similarity, the reactivity towards several subunits of antibodies once thought to be subunit specific becomes a likely possibility. Hence, an immunomethod that utilizes cells expressing an array of related subunits is a convenient and necessary tool to characterize such antibodies. Furthermore, modifications of this method should also permit an investigation into intracellular processing assembly and transport (Hurtley and Helenius, 1989) as well as receptor insertion into the cell surface of subunits expressed singly or in combination with others.
